Oppenheimer & CO Inc Emergent Bio Solutions Inc. Transaction History

Oppenheimer & CO Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 11, 2021	SELL	$79.17 - $111.47 $335,680 - $472,632	-4,240 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$81.91 - $134.94 $6,388 - $10,525	78 Added 1.87%	4,240 $438,000
Q2 2020 Aug 11, 2020	BUY	$54.33 - $89.52 $226,121 - $372,582	4,162 New	4,162 $329,000

160

33.8M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $442M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Oppenheimer & CO Inc with notifications on news.